Advertisement

3D Bioprinting pp 199-215 | Cite as

Bioprinting for Human Respiratory and Gastrointestinal In Vitro Models

  • Manuela Estermann
  • Christoph Bisig
  • Dedy Septiadi
  • Alke Petri-Fink
  • Barbara Rothen-RutishauserEmail author
Protocol
  • 94 Downloads
Part of the Methods in Molecular Biology book series (MIMB, volume 2140)

Abstract

Increasing ethical and biological concerns require a paradigm shift toward animal-free testing strategies for drug testing and hazard assessments. To this end, the application of bioprinting technology in the field of biomedicine is driving a rapid progress in tissue engineering. In particular, standardized and reproducible in vitro models produced by three-dimensional (3D) bioprinting technique represent a possible alternative to animal models, enabling in vitro studies relevant to in vivo conditions. The innovative approach of 3D bioprinting allows a spatially controlled deposition of cells and biomaterial in a layer-by-layer fashion providing a platform for engineering reproducible models. However, despite the promising and revolutionizing character of 3D bioprinting technology, standardized protocols providing detailed instructions are lacking. Here, we provide a protocol for the automatized printing of simple alveolar, bronchial, and intestine epithelial cell layers as the basis for more complex respiratory and gastrointestinal tissue models. Such systems will be useful for high-throughput toxicity screening and drug efficacy evaluation.

Key words

In vitro cultures Alveolar epithelial cells Bronchial epithelial cells Intestine epithelial cells Bioprinting technique 

Notes

Acknowledgments

This work was supported by the Swiss National Science Foundation (grant number CRSII5_171037), the Run4Science grant, and the Adolphe Merkle Foundation.

References

  1. 1.
    Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4–21.  https://doi.org/10.1093/toxsci/kfm169CrossRefPubMedGoogle Scholar
  2. 2.
    Hartung T, Rovida C (2009) Chemical regulators have overreached. Nature 460:1080–1081.  https://doi.org/10.1038/4601080aCrossRefPubMedGoogle Scholar
  3. 3.
    Shukla SJ, Huang R, Austin CP, Xia M (2010) Foundation review: the future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15:997–1007.  https://doi.org/10.1016/j.drudis.2010.07.007CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Astashkina A, Mann B, Grainger DW (2012) A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther 134:82–106.  https://doi.org/10.1016/j.pharmthera.2012.01.001CrossRefPubMedGoogle Scholar
  5. 5.
    Xia M, Huang R, Witt KL et al (2008) Compound cytotoxicity profiling using quantitative high-throughput screening. Environ Health Perspect 116:284–291.  https://doi.org/10.1289/ehp.10727CrossRefPubMedGoogle Scholar
  6. 6.
    OECD (2015) Test No. 439: In vitro skin irritation: reconstructed human epidermis test method. OECD Publishing, ParisGoogle Scholar
  7. 7.
    Murphy SV, Atala A (2014) 3D bioprinting of tissues and organs. Nat Biotechnol 32:773–785.  https://doi.org/10.1038/nbt.2958CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Wüst S, Godla ME, Müller R, Hofmann S (2014) Tunable hydrogel composite with two-step processing in combination with innovative hardware upgrade for cell-based three-dimensional bioprinting. Acta Biomater 10:630–640.  https://doi.org/10.1016/J.ACTBIO.2013.10.016CrossRefPubMedGoogle Scholar
  9. 9.
    Pati F, Jang J, Ha D-H et al (2014) Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun 5:3935.  https://doi.org/10.1038/ncomms4935CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Horváth L, Umehara Y, Jud C et al (2015) Engineering an in vitro air-blood barrier by 3D bioprinting. Sci Rep 5:7974.  https://doi.org/10.1038/srep07974CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lieber M, Todaro G, Smith B et al (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62–70.  https://doi.org/10.1002/ijc.2910170110CrossRefPubMedGoogle Scholar
  12. 12.
    Shapiro DL, Nardone LL, Rooney SA et al (1978) Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II alveolar epithelial cells. Biochim Biophys Acta 530:197–207.  https://doi.org/10.1016/0005-2760(78)90005-XCrossRefPubMedGoogle Scholar
  13. 13.
    Foster KA, Oster CG, Mayer MM et al (1998) Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 243:359–366.  https://doi.org/10.1006/EXCR.1998.4172CrossRefPubMedGoogle Scholar
  14. 14.
    Foldbjerg R, Dang DA, Autrup H (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–750.  https://doi.org/10.1007/s00204-010-0545-5CrossRefPubMedGoogle Scholar
  15. 15.
    Forbes B, Ehrhardt C (2005) Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 60:193–205.  https://doi.org/10.1016/J.EJPB.2005.02.010CrossRefPubMedGoogle Scholar
  16. 16.
    Lehmann A, Brandenberger C, Blank F et al (2010) A 3D model of the human epithelial airway barrier. In: Maguire D, Novik E (eds) Methods in bioengineering: Alternative technologies to animal testing. Artech House, London, pp S35–S36Google Scholar
  17. 17.
    Wan H, Winton HL, Soeller C, et al (2000) Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur Respir J 15:1058–1068Google Scholar
  18. 18.
    Cozens AL, Yezzi MJ, Kunzelmann K et al (1994) CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10:38–47.  https://doi.org/10.1165/ajrcmb.10.1.7507342CrossRefPubMedGoogle Scholar
  19. 19.
    Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736–749CrossRefGoogle Scholar
  20. 20.
    Sambuy Y, De Angelis I, Ranaldi G et al (2005) The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1–26.  https://doi.org/10.1007/s10565-005-0085-6CrossRefPubMedGoogle Scholar
  21. 21.
    Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880–885.  https://doi.org/10.1016/0006-291X(91)91647-UCrossRefPubMedGoogle Scholar
  22. 22.
    Fratzl P (2008) Collagen: structure and mechanics, an introduction. In: Collagen. Springer US, Boston, MA, pp 1–13CrossRefGoogle Scholar
  23. 23.
    Legrand C, Bour JM, Jacob C et al (1992) Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker. J Biotechnol 25:231–243.  https://doi.org/10.1016/0168-1656(92)90158-6CrossRefPubMedGoogle Scholar
  24. 24.
    Balda MS, Whitney JA, Flores C et al (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031–1049.  https://doi.org/10.1083/JCB.134.4.1031CrossRefPubMedGoogle Scholar
  25. 25.
    Velegol D, Lanni F (2001) Cell traction forces on soft biomaterials. I. Microrheology of type I collagen gels. Biophys J 81:1786–1792.  https://doi.org/10.1016/S0006-3495(01)75829-8CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Williams BR, Gelman RA, Poppke DC, Piez KA (1978) Collagen fibril formation. Optimal in vitro conditions and preliminary kinetic results. J Biol Chem 253:6578–6585PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  • Manuela Estermann
    • 1
  • Christoph Bisig
    • 1
    • 2
  • Dedy Septiadi
    • 1
  • Alke Petri-Fink
    • 1
  • Barbara Rothen-Rutishauser
    • 1
    Email author
  1. 1.Adolphe Merkle InstituteUniversity of FribourgFribourgSwitzerland
  2. 2.Comprehensive Molecular AnalyticsHelmholtz Center MunichMunichGermany

Personalised recommendations